TOI files notice to sell 23,452 common shares

TOI reports a Form 144 notice for the potential sale of 23,452 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an aggregate market value of $146,575.00.

Rhea-AI Filing Summary

TOI reports a Form 144 notice for the potential sale of 23,452 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an aggregate market value of $146,575.00. The shares are shown as acquired on 07/14/2026 via an Exercise of Stock Options from the issuer for cash.

The filing also lists recent Rule 10b5-1 sales by Yale D. Podnos: on 06/08/2026, 23,451 common shares for $126,093.70, and on 05/21/2026, 1,805 common shares for $8,068.35.

Key Figures

Proposed shares to be sold: 23,452 shares of common stock Aggregate market value of proposed sale: $146,575.00 CUSIP: 99982933 +4 more

7 metrics

Proposed shares to be sold 23,452 shares of common stock Listed as securities to be sold through Morgan Stanley Smith Barney on NASDAQ

Aggregate market value of proposed sale $146,575.00 Value attributed to the 23,452 common shares to be sold

CUSIP 99982933 Identifier associated with the common stock class in the notice

Shares sold on 06/08/2026 23,451 shares Rule 10b5-1 sale of common stock by Yale D. Podnos

Proceeds from 06/08/2026 sale $126,093.70 Consideration received for 23,451 common shares

Shares sold on 05/21/2026 1,805 shares Additional sale of common stock by Yale D. Podnos

Proceeds from 05/21/2026 sale $8,068.35 Consideration received for 1,805 common shares

Key Terms

Securities To Be Sold, Exercise of Stock Options, 10b5-1 Sales

3 terms

Securities To Be Sold regulatory

"Section labeled "144: Securities To Be Sold" for the common stock"

Exercise of Stock Options financial

"Acquisition method listed as "Exercise of Stock Options" on 07/14/2026"

10b5-1 Sales regulatory

"Header "10b5-1 Sales for YALE D PODNOS" describing prior transactions"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What share sale does TOI report in this Form 144 notice?

The notice lists a potential sale of 23,452 shares of TOI common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with the transaction disclosed under the Form 144 "Securities To Be Sold" section.

What is the reported value of the 23,452 TOI shares to be sold?

The filing shows an aggregate market value of $146,575.00 for the 23,452 common shares to be sold. This value is tied directly to the common stock class identified in the Form 144 notice.

How were the TOI shares in the Form 144 notice acquired?

The shares are reported as acquired on 07/14/2026 through an Exercise of Stock Options from the issuer, with the consideration listed as cash. This acquisition method is specified in the "Securities To Be Sold" details.

Which broker is named for the proposed TOI share sale?

The proposed sale is associated with Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. This broker is listed alongside the common stock and share amount in the notice.

What prior Rule 10b5-1 sales by Yale D. Podnos are disclosed for TOI?

The Form 144 lists "10b5-1 Sales for YALE D PODNOS": on 06/08/2026, a sale of 23,451 common shares for $126,093.70, and on 05/21/2026, a sale of 1,805 common shares for $8,068.35.

On which exchange is the TOI common stock in this notice traded?

The common stock referenced in the Form 144 notice is listed as traded on NASDAQ. This exchange designation appears with the common stock and other security identifiers in the filing details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/14/2026 - 04:33 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001891104
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	The Oncology Institute, Inc.
SEC File Number	001-39248
Address of Issuer	18000 Studebaker Road, Suite 800 Cerritos CALIFORNIA 90703
Phone	562-735-3226
Name of Person for Whose Account the Securities are To Be Sold	YALE PODNOS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	23452	146575.00	99982933	07/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/14/2026	Exercise of Stock Options	Issuer			23452	07/14/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for YALE D PODNOS 18000 Studebaker Road, Suite 800 Cerritos CA 90703	COMMON	06/08/2026	23451	126093.70
YALE PODNOS 18000 Studebaker Road, Suite 800 Cerritos CA 90703	Common	05/21/2026	1805	8068.35

144: Remarks and Signature

Remarks
Date of Notice	07/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Yale Podnos
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)